RCKT - Rocket Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

RCKT is currently covered by 8 analysts with an average price target of $23.13. This is a potential upside of $19.74 (582.3%) from yesterday's end of day stock price of $3.39.

Rocket Pharmaceuticals's activity chart (see below) currently has 109 price targets and 112 ratings on display. The stock rating distribution of RCKT is 83.87% BUY and 16.13% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 19.13% with an average time for these price targets to be met of 150.5 days.

Highest price target for RCKT is $11, Lowest price target is $2, average price target is $6.8.

Most recent stock forecast was given by MANI FOROOHAR from LEERINK on 03-Oct-2025. First documented stock forecast 27-Nov-2018.

Currently out of the existing stock ratings of RCKT, 26 are a BUY (83.87%), 5 are a HOLD (16.13%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

$7

$3.85 (122.22%)

$8

5 days ago
(03-Oct-2025)

1/11 (9.09%)

$3.85 (122.22%)

374

Buy

$11

$7.85 (249.21%)

$11

1 months 18 days ago
(20-Aug-2025)

3/15 (20%)

$7.25 (193.33%)

140

Buy

$4

$0.85 (26.98%)

$19

2 months 13 days ago
(25-Jul-2025)

1/8 (12.5%)

$0.86 (27.39%)

145

Buy

$10

$6.85 (217.46%)

$11

2 months 13 days ago
(25-Jul-2025)

0/10 (0%)

$6.86 (218.47%)

Hold

$42

2 months 14 days ago
(24-Jul-2025)

0/18 (0%)

$39.67 (1702.58%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is RCKT (Rocket Pharmaceuticals) average time for price targets to be met?

On average it took 150.5 days on average for the stock forecasts to be realized with a an average price target met ratio 19.13

Which analyst has the current highest performing score on RCKT (Rocket Pharmaceuticals) with a proven track record?

ESTHER RAJAVELU

Which analyst has the most public recommendations on RCKT (Rocket Pharmaceuticals)?

Esther Rajavelu has 8 price targets and 3 ratings on RCKT

Which analyst is the currently most bullish on RCKT (Rocket Pharmaceuticals)?

Joshua Schimmer with highest potential upside - $56.4

Which analyst is the currently most reserved on RCKT (Rocket Pharmaceuticals)?

Richard Law with lowest potential downside - -$1.15

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?